Process of treating inflammation with human urinary thiol protea

Details Process of treating inflammation with human urinary thiol protea Process of treating inflammation with human urinary thiol protea

1983-08-19

1984-10-30

Rosen, Sam

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

A61K 3522

Patent

active

044799373

ABSTRACT:
An anti-inflammatory agent comprising as an active component an inhibitor specifically inhibiting a thiol protease, which is obtained from human urine by extraction and purification. This agent has an action of inhibiting a disease caused by a thiol protease. This anti-inflammatory agent is prepared by a process in which a thiol protease inhibitor is extracted and purified from human urine by adopting in combination at least two treatments selected from a treatment with a molecular filter, a treatment with an ion exchanger, a treatment with an adsorber and an affinity chromatographic treatment.

REFERENCES:
Muramatsu et al., Chem. Abst., vol. 86, (1977), p. 52201m.
Sato et al., Chem. Abst., vol. 96, (1982), p. 48193z.

Affiliated with

Also associated with

Rating

Process of treating inflammation with human urinary thiol protea does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process of treating inflammation with human urinary thiol protea, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process of treating inflammation with human urinary thiol protea will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1101804